Indonesia Rejects Complaints About New Drug Production Rule
This article was originally published in PharmAsia News
Executive Summary
Indonesia's health minister dismissed complaints about new rules requiring foreign drug makers to have a local production facility before they can sell in the country. Minister Siti Fadilah Supari said the intent of the new rules was to force the companies to invest in the country instead of taking advantage of its potential for sales. Thirteen multinational pharmaceuticals are affected by the rule since they market products in the country, but do not have a production facility in Indonesia. A U.S. business group complained about the rule that requires foreign pharmas to establish production facilities in Indonesia within two years or stop selling their products in the $2 billion-a-year market. Critics of the rule say it could lead to a lack of some life-saving drugs in Indonesia. (Click here for more